6850 Stock Overview
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
BiOptic Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$49.50 |
52 Week High | NT$61.40 |
52 Week Low | NT$45.45 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | -1.20% |
1 Year Change | 6.35% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 6.96% |
Recent News & Updates
Recent updates
Shareholder Returns
6850 | TW Medical Equipment | TW Market | |
---|---|---|---|
7D | 1.0% | 3.0% | 4.0% |
1Y | 6.3% | 5.4% | 28.5% |
Return vs Industry: 6850 matched the TW Medical Equipment industry which returned 5.4% over the past year.
Return vs Market: 6850 underperformed the TW Market which returned 28.5% over the past year.
Price Volatility
6850 volatility | |
---|---|
6850 Average Weekly Movement | 2.7% |
Medical Equipment Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in TW Market | 8.7% |
10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6850 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6850's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | n/a | n/a | www.bioptic.com.tw |
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.
BiOptic Inc. Fundamentals Summary
6850 fundamental statistics | |
---|---|
Market cap | NT$1.32b |
Earnings (TTM) | NT$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6850 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6850 income statement (TTM) | |
---|---|
Revenue | NT$0 |
Cost of Revenue | NT$0 |
Gross Profit | NT$0 |
Other Expenses | NT$0 |
Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 6850 perform over the long term?
See historical performance and comparison